Prevention of HPV-associated oropharyngeal squamous cell cancer (OPSCC)

Kurssin aikataulu

• 09:00

  Epidemiology of OPSCC

• 09:00

  Word-wide occurrence of oropharyngeal cancer

  Dr. Iacopo Baussano International Agency for Research on Cancer (IARC)
  

• 09:30

  Oropharyngeal cancer trends in the Nordic countries

  Dr. Tuomas Lehtinen FICAN-Mid
  

• 10:00

  Familial occurrence of OPSCC and other HPV-associated cancers

  Dr. Kari Hemminki Deutsches Krebsforschungszentrum (DKFZ)
  

• 10:30

  Tauko

• 11:00

  Biological basis and means of OPSCC elimination

• 11:00

  The relative role of HPV in oropharyngeal cancer

  Dr. Massimo Tommasino IARC
  

• 11:30

  Efficacy of vaccination against oropharyngeal HPV infection

  Dr. Dan Apter
  

• 12:00

  Tauko

• 13:00

  Screening of HPV-associated OPSCC – the Hamburg trial

  Dr. Michael Pawlita DKFZ
  

• 13:30

  Risk-stratified screening of OPSCC – the Finnish trial

  Dr. Matti Lehtinen THL
  

• 14:00

  Tauko

• 14:30

  Cost-effectiveness of OPSCC elimination

• 14:30

  Management of HPV-positive and HPV-negative OPSCC

  Dr. Antti Mäkitie University of Helsinki
  

• 15:00

  Cost-effectiveness of eliminating HPV-associated OPSCC

  Dr. Simopekka Vänskä Finnish Institute for Health and Welfare (THL)
  

• 15:30

  Eradication of oncogenic HPV types – the ultimate goal

  Dr. Joakim Dillner Karolinska Institute